{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Fatty+Acid+Type&page=3", "query": { "condition": "Fatty Acid Type", "page": 3 }, "page_size": 10 }, "pagination": { "page": 3, "page_size": 10, "total_count": 52, "total_pages": 6, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Fatty+Acid+Type&page=4&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Fatty+Acid+Type&page=2&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-10T21:45:04.711Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00323414", "title": "Polyunsaturated Fatty Acids (PUFA) in Diabetic Fatty Liver", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Fatty Liver" ], "interventions": [ { "name": "Polyunsaturated fatty acid (Opti-EPA)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 37, "start_date": "2006-04", "completion_date": "2011-12", "has_results": true, "last_update_posted_date": "2018-02-23", "last_synced_at": "2026-11-10T21:45:04.711Z", "location_count": 2, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" }, { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00323414" }, { "nct_id": "NCT01996566", "title": "Fatty Acid Taste Thresholds: Caproic, Lauric, Oleic, Linoleic, Linolenic", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Taste Sensitivity", "Fatty Acid Type" ], "interventions": [], "intervention_types": [], "sponsor": "Purdue University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 30, "start_date": "2013-01", "completion_date": "2015-08", "has_results": false, "last_update_posted_date": "2015-10-15", "last_synced_at": "2026-11-10T21:45:04.711Z", "location_count": 1, "location_summary": "West Lafayette, Indiana", "locations": [ { "city": "West Lafayette", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT01996566" }, { "nct_id": "NCT01869764", "title": "Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Ductal Breast Carcinoma in Situ", "Lobular Breast Carcinoma in Situ", "Male Breast Cancer", "Stage IA Breast Cancer", "Stage IB Breast Cancer", "Stage II Breast Cancer", "Stage IIIA Breast Cancer", "Stage IIIB Breast Cancer", "Stage IIIC Breast Cancer" ], "interventions": [ { "name": "omega-3 fatty acid", "type": "DRUG" }, { "name": "placebo", "type": "OTHER" }, { "name": "laboratory biomarker analysis", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Wake Forest University Health Sciences", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 57, "start_date": "2013-11", "completion_date": "2018-07", "has_results": true, "last_update_posted_date": "2019-10-30", "last_synced_at": "2026-11-10T21:45:04.711Z", "location_count": 1, "location_summary": "Winston-Salem, North Carolina", "locations": [ { "city": "Winston-Salem", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01869764" }, { "nct_id": "NCT05144347", "title": "Study of XL114 in Subjects With Non-Hodgkin's Lymphoma", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Non-Hodgkin's Lymphoma (NHL)", "Activated B-Cell Type Diffuse Large B-Cell Lymphoma (ABC-DLBCL)", "Mantle Cell Lymphoma (MCL)", "Chronic Lymphocytic Leukemia (CLL)", "Small Lymphocytic Lymphoma (SLL)" ], "interventions": [ { "name": "XL114", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Exelixis", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2, "start_date": "2022-04-12", "completion_date": "2022-11-01", "has_results": false, "last_update_posted_date": "2023-07-11", "last_synced_at": "2026-11-10T21:45:04.711Z", "location_count": 4, "location_summary": "Tucson, Arizona • Indianapolis, Indiana • Pittsburgh, Pennsylvania + 1 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Pittsburgh", "state": "Pennsylvania" }, { "city": "Spokane", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT05144347" }, { "nct_id": "NCT03689738", "title": "Effects of Potato Resistant Starch Intake on Insulin Sensitivity, Related Metabolic Markers and Satiety", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Insulin Sensitivity", "Lipid Metabolism", "Resistant Starch", "Potato" ], "interventions": [ { "name": "Potato (Resistant Starch)", "type": "OTHER" }, { "name": "CHO-matched (Low-fiber, RS-free)", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Midwest Center for Metabolic and Cardiovascular Research", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "74 Years", "sex": "ALL", "summary": "18 Years to 74 Years" }, "enrollment_count": 24, "start_date": "2018-09-24", "completion_date": "2019-02-20", "has_results": false, "last_update_posted_date": "2019-07-25", "last_synced_at": "2026-11-10T21:45:04.711Z", "location_count": 1, "location_summary": "Boca Raton, Florida", "locations": [ { "city": "Boca Raton", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03689738" }, { "nct_id": "NCT06195306", "title": "Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Breast Atypical Hyperplasia", "Breast Carcinoma", "Breast Ductal Carcinoma In Situ", "Breast Lobular Carcinoma In Situ" ], "interventions": [ { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Mammography", "type": "PROCEDURE" }, { "name": "Omega-3-Acid Ethyl Esters", "type": "DRUG" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Random Periareolar Fine-Needle Aspiration", "type": "PROCEDURE" }, { "name": "Tamoxifen", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "DRUG", "OTHER" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "45 Years", "maximum_age": "74 Years", "sex": "FEMALE", "summary": "45 Years to 74 Years · Female only" }, "enrollment_count": 66, "start_date": "2025-07-28", "completion_date": "2028-01-01", "has_results": false, "last_update_posted_date": "2026-08-04", "last_synced_at": "2026-11-10T21:45:04.711Z", "location_count": 3, "location_summary": "Kansas City, Kansas • Ann Arbor, Michigan • Columbus, Ohio", "locations": [ { "city": "Kansas City", "state": "Kansas" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT06195306" }, { "nct_id": "NCT04006847", "title": "Omega -3 Fatty Acid in Combination With Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Chronic Myeloid Leukemia, Chronic Phase" ], "interventions": [ { "name": "Eicosapentaenoic Acid", "type": "DRUG" }, { "name": "Tyrosine kinase inhibitor", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Milton S. Hershey Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1, "start_date": "2020-09-14", "completion_date": "2021-05-21", "has_results": true, "last_update_posted_date": "2022-07-01", "last_synced_at": "2026-11-10T21:45:04.711Z", "location_count": 1, "location_summary": "Hershey, Pennsylvania", "locations": [ { "city": "Hershey", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT04006847" }, { "nct_id": "NCT00607945", "title": "Dietary Fatty Acids As Complementary Therapy in Type 2 Diabetes Mellitus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Type 2 Diabetes Mellitus" ], "interventions": [ { "name": "Rosiglitazone (Avandia) OR other diabetes medication currently prescribed to participant", "type": "DRUG" }, { "name": "conjugated linoleic acid (CLA)", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DRUG", "DIETARY_SUPPLEMENT" ], "sponsor": "Ohio State University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "30 Years to 70 Years" }, "enrollment_count": 48, "start_date": "2008-01", "completion_date": "2012-05", "has_results": false, "last_update_posted_date": "2024-10-29", "last_synced_at": "2026-11-10T21:45:04.711Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00607945" }, { "nct_id": "NCT00592072", "title": "Effect of Medium Chain Fatty Acids on Cognitive Function During Acute Hypoglycemia in Patients With Type 1 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diabetes Mellitus, Type 1" ], "interventions": [ { "name": "Medium chain fatty acid (Octanoic and Decanoic acid)", "type": "DIETARY_SUPPLEMENT" }, { "name": "Splenda (Placebo Control)", "type": "OTHER" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "OTHER" ], "sponsor": "Yale University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 12, "start_date": "2005-07", "completion_date": "2008-07", "has_results": true, "last_update_posted_date": "2015-01-22", "last_synced_at": "2026-11-10T21:45:04.711Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT00592072" }, { "nct_id": "NCT01580813", "title": "Evaluating the Effects of a Study Medication on Exercise Function in Type 2 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Type 2 Diabetes" ], "interventions": [ { "name": "Acipimox", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Colorado, Denver", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "30 Years to 60 Years" }, "enrollment_count": 13, "start_date": "2011-06", "completion_date": "2015-06-05", "has_results": true, "last_update_posted_date": "2021-12-03", "last_synced_at": "2026-11-10T21:45:04.711Z", "location_count": 1, "location_summary": "Aurora, Colorado", "locations": [ { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT01580813" } ] }